Shuttle Pharmaceuticals Holdings, Inc.
SHPH
Transaktioner
54
Köp
16
Sälj
38
Nettoinsynsflöde
-747 k USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
54 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2026-07-14 | HRT FINANCIAL LP | 10% owner | Sell | 82 k | 4,48 | 368 k USD |
| 2026-07-14 | HRT FINANCIAL LP | 10% owner | Sell | 82 k | 4,48 | 368 k USD |
| 2026-07-13 | HRT FINANCIAL LP | 10% owner | Sell | 1 k | 4,67 | 5 k USD |
| 2026-07-13 | HRT FINANCIAL LP | 10% owner | Sell | 1 k | 4,67 | 5 k USD |
| 2026-07-10 | HRT FINANCIAL LP | 10% owner | Buy | 731 | 3,11 | 2 k USD |
| 2026-07-10 | HRT FINANCIAL LP | 10% owner | Buy | 731 | 3,11 | 2 k USD |
| 2026-07-09 | HRT FINANCIAL LP | 10% owner | Buy | 8 k | 3,38 | 28 k USD |
| 2026-07-09 | HRT FINANCIAL LP | 10% owner | Buy | 8 k | 3,38 | 28 k USD |
| 2026-07-08 | HRT FINANCIAL LP | 10% owner | Sell | 19 k | 3,52 | 65 k USD |
| 2026-07-08 | HRT FINANCIAL LP | 10% owner | Sell | 19 k | 3,52 | 65 k USD |
| 2026-07-07 | HRT FINANCIAL LP | 10% owner | Sell | 11 k | 3,33 | 35 k USD |
| 2026-07-07 | HRT FINANCIAL LP | 10% owner | Sell | 11 k | 3,33 | 35 k USD |
| 2026-07-06 | HRT FINANCIAL LP | 10% owner | Sell | 9 k | 3,51 | 32 k USD |
| 2026-07-06 | HRT FINANCIAL LP | 10% owner | Sell | 9 k | 3,51 | 32 k USD |
| 2026-07-02 | HRT FINANCIAL LP | 10% owner | Buy | 8 k | 3,54 | 28 k USD |
| 2026-07-02 | HRT FINANCIAL LP | 10% owner | Buy | 8 k | 3,54 | 28 k USD |
| 2026-07-01 | HRT FINANCIAL LP | 10% owner | Buy | 4 k | 3,30 | 13 k USD |
| 2026-07-01 | HRT FINANCIAL LP | 10% owner | Buy | 4 k | 3,30 | 13 k USD |
| 2026-06-30 | HRT FINANCIAL LP | 10% owner | Buy | 7 k | 3,23 | 22 k USD |
| 2026-06-30 | HRT FINANCIAL LP | 10% owner | Buy | 7 k | 3,23 | 22 k USD |
| 2026-06-29 | HRT FINANCIAL LP | 10% owner | Buy | 26 k | 3,44 | 89 k USD |
| 2026-06-29 | HRT FINANCIAL LP | 10% owner | Buy | 26 k | 3,44 | 89 k USD |
| 2024-05-01 | Jung Mira | Chief Scientific Officer | Sell | 598 | 11,28 | 7 k USD |
| 2024-05-01 | Jung Mira | Chief Scientific Officer | Sell | 598 | 11,28 | 7 k USD |
| 2024-03-08 | Vander Hoek Michael | Chief Financial Officer | Buy | 100 k | 0,00 | 0 USD |
| 2024-03-08 | Vander Hoek Michael | Chief Financial Officer | Buy | 100 k | 0,00 | 0 USD |
| 2023-12-13 | Brown Milton | Director | Sell | 3 k | 0,46 | 1 k USD |
| 2023-12-13 | Brown Milton | Director | Sell | 3 k | 0,46 | 1 k USD |
| 2023-12-13 | Jacobs Bette | Director | Sell | 4 k | 0,46 | 2 k USD |
| 2023-12-13 | Jacobs Bette | Director | Sell | 4 k | 0,46 | 2 k USD |
| 2023-08-14 | Dritschilo Anatoly | CEO and Chairman | Sell | 2.1 mn | 0,00 | 0 USD |
| 2023-08-14 | Dritschilo Anatoly | CEO and Chairman | Buy | 2.1 mn | 0,00 | 0 USD |
| 2023-08-14 | Dritschilo Anatoly | CEO and Chairman | Sell | 2.1 mn | 0,00 | 0 USD |
| 2023-08-14 | Dritschilo Anatoly | CEO and Chairman | Buy | 2.1 mn | 0,00 | 0 USD |
| 2022-12-29 | Senanayake Chris | Director | Sell | 2 k | 1,61 | 3 k USD |
| 2022-12-29 | Senanayake Chris | Director | Sell | 2 k | 1,61 | 3 k USD |
| 2022-12-29 | Richards Steven M | Director | Sell | 995 | 1,61 | 2 k USD |
| 2022-12-29 | Richards Steven M | Director | Sell | 995 | 1,61 | 2 k USD |
| 2022-12-29 | Adkins William | – | Sell | 995 | 1,61 | 2 k USD |
| 2022-12-29 | Brown Milton | Director | Sell | 995 | 1,61 | 2 k USD |
| 2022-12-29 | Brown Milton | Director | Sell | 995 | 1,61 | 2 k USD |
| 2022-12-29 | Adkins William | – | Sell | 995 | 1,61 | 2 k USD |
| 2022-12-29 | Dritschilo Anatoly | CEO and Chairman | Sell | 8 k | 1,61 | 13 k USD |
| 2022-12-29 | Jacobs Bette | Director | Sell | 4 k | 1,61 | 7 k USD |
| 2022-12-29 | Jung Mira | Chief Scientific Officer | Sell | 328 | 1,61 | 526 USD |
| 2022-12-29 | Rich Tyvin | Chief Medical Officer | Sell | 1 k | 1,61 | 2 k USD |
| 2022-12-29 | Jacobs Bette | Director | Sell | 4 k | 1,61 | 7 k USD |
| 2022-12-29 | Jung Mira | Chief Scientific Officer | Sell | 328 | 1,61 | 526 USD |
| 2022-12-29 | Rich Tyvin | Chief Medical Officer | Sell | 1 k | 1,61 | 2 k USD |
| 2022-12-29 | Dritschilo Anatoly | CEO and Chairman | Sell | 8 k | 1,61 | 13 k USD |
| 2022-12-29 | Dritschilo Peter | President and COO | Sell | 4 k | 1,61 | 6 k USD |
| 2022-12-29 | Vander Hoek Michael | Chief Financial Officer | Sell | 2 k | 1,61 | 4 k USD |
| 2022-12-29 | Dritschilo Peter | President and COO | Sell | 4 k | 1,61 | 6 k USD |
| 2022-12-29 | Vander Hoek Michael | Chief Financial Officer | Sell | 2 k | 1,61 | 4 k USD |